XML 55 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Tables)
12 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Information

 

   2025   2024 
   Years ended September 30, 
   2025   2024 
Research and development:          
Clinical  $5,632,217   $2,613,188 
Non-clinical   2,260,300    3,888,787 
Other(1)   462,787    (764,723)
Total research and development   8,355,304    5,737,252 
General and administrative:          
Payroll and related   1,716,552    715,846 
Professional fees   3,695,790    1,922,292 
Consulting   1,314,698    1,532,601 
Other(2)   1,761,771    1,960,106 
Total general and administrative   8,488,811    6,130,845 
Operating expenses  $16,844,115   $11,868,097 

 

(1) Other research and development consists primarily of payroll and related expenses and dues, licenses and subscriptions. The balance is negative for the year ended September 30, 2024 due to the cancellation of accrued but unpaid bonuses that had been awarded for fiscal years 2022 and 2023.
(2) Other general and administrative consists primarily of facilities, insurance, filing fees, travel expenses and franchise taxes.